Global Insulin Aspart Market Size & Outlook, 2026-2033
Global insulin aspart market, 2021-2033 (US$M)
Related Markets
Global insulin aspart market highlights
- The global insulin aspart market generated a revenue of USD 3,520.0 million in 2025 and is expected to reach USD 5,019.8 million by 2033.
- The market is expected to grow at a CAGR (2026 - 2033) of 4.6% by 2033.
- In terms of segment, branded accounted for a revenue of USD 2,640.3 million in 2025.
- Biosimilar is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2025.
- Country-wise, China is expected to register the highest CAGR from 2026 to 2033.
Global data book summary
| Market revenue in 2025 | USD 3,520.0 million |
| Market revenue in 2033 | USD 5,019.8 million |
| Growth rate | 4.6% (CAGR from 2026 to 2033) |
| Largest segment | Branded |
| Fastest growing segment | Biosimilar |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Branded, Biosimilar |
Other key industry trends
- In terms of revenue, the North America accounted for 41.5% of the global insulin aspart market in 2025.
- By country, the Canada is projected to lead the global market in terms of revenue in 2033.
- By country, China is the fastest growing regional market and is projected to reach USD 649.6 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Insulin Aspart Market Scope
Insulin Aspart Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Geropharm | View profile | 1001-5000 | Saint Petersburg, Saint Petersburg City, Russian Federation, Europe | http://geropharm.com |
| Gan & Lee Pharmaceutical | View profile | 1001-5000 | Beijing, Beijing, China, Asia | http://www.ganlee.com |
| United Laboratories International Holdings Limited | View profile | - | - | - |
| Tonghua Dongbao Pharmaceutical Co. Ltd | View profile | - | - | - |
| Sedico | View profile | - | - | |
| Julphar | View profile | 1001-5000 | Khaimah, Ras Al Khaimah, United Arab Emirates, Asia | http://julphar.net |
| Wockhardt | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://wockhardt.com |
| Biocon | View profile | 10001+ | Bangalore, Karnataka, India, Asia | http://www.biocon.com |
| Novo Nordisk A/S ADR | View profile | 66015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | https://www.novonordisk.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
Global insulin aspart market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to insulin aspart market will help companies and investors design strategic landscapes.
Branded was the largest segment with a revenue share of 75.01% in 2025. Horizon Databook has segmented the Global insulin aspart market based on branded, biosimilar covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Insulin Aspart Product Outlook (Revenue, USD Million, 2021-2033)
- Branded
- Biosimilar
- Global Insulin Aspart Application Outlook (Revenue, USD Million, 2021-2033)
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
- Global Insulin Aspart Distribution Channel Outlook (Revenue, USD Million, 2021-2033)
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
- Government / Institutional tenders
Reasons to subscribe to Global insulin aspart market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global insulin aspart market databook
-
Our clientele includes a mix of insulin aspart market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global insulin aspart market , including forecasts for subscribers. This global databook contains high-level insights into Global insulin aspart market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global insulin aspart market size, by regions, 2021-2033 (US$M)
Top 10 countries: Insulin aspart market size, 2025 (US$M)
Global insulin aspart market share, by product, 2025 & 2033 (%, US$M)
Insulin aspart market: Opportunity assessment by country
Global insulin aspart market, by region, 2025 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
